Persistence of prolonged C-peptide production in type 1 diabetes as measured with an ultrasensitive C-peptide assay - Wikidata - wikimedia - TriplyDB

Persistence of prolonged C-peptide production in type 1 diabetes as measured with an ultrasensitive C-peptide assay

Persistence of prolonged C-peptide production in type 1 diabetes as measured with an ultrasensitive C-peptide assay

http://www.wikidata.org/entity/Q24600478

about

A Practical Review of C-Peptide Testing in Diabetes The Clinical Course of Patients with Preschool Manifestation of Type 1 Diabetes Is Independent of the HLA DR-DQ Genotype Distribution of C-peptide and its determinants in North American children at risk for type 1 diabetes.Metabolic abnormalities in the pathogenesis of type 1 diabetes.Insulin secretion measured by stimulated C-peptide in long-established Type 1 diabetes in the Diabetes Control and Complications Trial (DCCT)/ Epidemiology of Diabetes Interventions and Complications (EDIC) cohort: a pilot study.Stem cell educator therapy and induction of immune balance.Low levels of C-peptide have clinical significance for established Type 1 diabetes.Pancreas transplantation in type II diabetes mellitus.Complex multi-block analysis identifies new immunologic and genetic disease progression patterns associated with the residual β-cell function 1 year after diagnosis of type 1 diabetes.Rapid model exploration for complex hierarchical data: application to pharmacokinetics of insulin aspart.Betatrophin in Diabetes Mellitus: the Epidemiological Evidence in Humans.Switching from Twice-Daily Basal Insulin Injections to Once-Daily Insulin Degludec Injection for Basal-Bolus Insulin Regimen in Japanese Patients with Type 1 Diabetes: A Pilot Study.Residual C-peptide in patients with Type 1 diabetes and multiethnic backgrounds.Variations in rodent models of type 1 diabetes: islet morphology.Blockade of glucagon signaling prevents or reverses diabetes onset only if residual β-cells persist.Exercise to preserve beta cell function in recent-onset type 1 diabetes mellitus (EXTOD)--a study protocol for a pilot randomized controlled trial Factors determining insulin requirements in women with type 1 diabetes mellitus during pregnancy: a review Insulitis in the pathogenesis of type 1 diabetes Prevention of type 1A diabetes mellitus Adjuvant Liraglutide and Insulin Versus Insulin Monotherapy in the Closed-Loop System in Type 1 Diabetes: A Randomized Open-Labeled Crossover Design Trial.The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells Increased circulating levels of betatrophin in individuals with long-standing type 1 diabetes.Pharmacokinetics of insulin aspart and glucagon in type 1 diabetes during closed-loop operation.Monogenic diabetes: a diagnostic algorithm for clinicians Potential role of non-insulin adjunct therapy in Type 1 diabetes.Endoplasmic reticulum stress, pancreatic β-cell degeneration, and diabetes.Residual C-peptide in type 1 diabetes: what do we really know?Transplant options for patients with type 2 diabetes and chronic kidney disease.The role of endoplasmic reticulum stress in human pathology.Revisiting multiple models of progression of β-cell loss of function in type 1 diabetes: Significance for prevention and cure.C-peptide antioxidant adaptive pathways in β cells and diabetes.The clinical potential of low-level C-peptide secretion.Sulfonylurea challenge test in subjects diagnosed with type 1 diabetes mellitus.Cohort Profile: Scottish Diabetes Research Network Type 1 Bioresource Study (SDRNT1BIO).Human beta cell mass and function in diabetes: Recent advances in knowledge and technologies to understand disease pathogenesis.Treg activation defect in type 1 diabetes: correction with TNFR2 agonism Most people with long-duration type 1 diabetes in a large population-based study are insulin microsecretors.Dead or alive?Pharmacokinetics of insulin aspart in pump-treated subjects with type 1 diabetes: reproducibility and effect of age, weight, and duration of diabetes.Why were we wrong for so long? The pancreas of type 1 diabetic patients commonly functions for decades.

P2860

Q33732640-8F3486BA-EDE1-4ECE-8C11-DA368AEBD90B Q33737477-94DB3880-A8F2-4964-9C12-A55D40C8DF47 Q33793803-6254C875-1986-4540-A4C9-B81BDD614C93 Q33940335-5BE7632A-FA78-4173-9F3F-16FD8044E13A Q34207348-CB1B482E-C2F7-4792-A669-5AB2A89497CC Q34290347-F76E8A7F-FF79-407F-9908-4A2BAE592894 Q34484912-4F3C0D25-A6CC-42F3-BA5A-DEAB16248E16 Q34761327-73D4B045-34B7-4E08-BE3F-9FE7E2FF27B4 Q34765755-BAFA765B-F7FB-4A9C-8DF3-42CC3608D001 Q35642529-BFBD2AFF-A4F2-4002-AB56-7BE499867DB4 Q35803552-FC231783-B00A-477B-BBE8-32D2218417AE Q36076126-1CCC9F3A-BD72-4714-BA16-492177635789 Q36555009-C84D73D2-4960-4085-A5E2-8B2A2FF4E312 Q36898677-97B25153-C479-415C-AE76-64843115990D Q36913461-AA7A3119-5E94-4831-850B-714A472C1E39 Q36958167-4F5D41B2-5615-44F2-B9ED-2F2B6F00EC45 Q37070253-8748BCB8-E046-456B-92B3-0171843E3719 Q37103789-D7B15406-4923-482F-8CAB-A0EFCD39B0A5 Q37158249-68BA4F0C-6D71-406B-B96F-C793875B55B6 Q37275418-4E78B0F4-1238-487C-98F3-ABD922C207D4 Q37374229-4888F23D-A151-4B19-A214-8617C1A1EF36 Q37374259-843495FB-356E-487A-8AE1-381B9F68ED7C Q37421571-C069C861-2F43-45B5-B459-1603C3C50EC3 Q37590415-20A05111-0E54-459F-94FF-9F43E9AACD31 Q38026900-CB42D22B-5316-4CA0-8238-8CC7ED02923C Q38040992-6302B018-8B11-4910-B150-B7C9B20F1874 Q38197230-CF81FE58-7719-412C-B2DC-D25BA3B30B88 Q38230451-EB297EB8-70FE-484D-91B1-8BEE828CEE08 Q38267105-1E7FBF9B-6919-4344-BDB4-648326D521BF Q38692770-1205C89A-3586-44DF-A939-C9263EC49956 Q38850708-E6820A38-F156-4549-BE8A-E10CD670185C Q38889362-77C5565B-9DAE-4E48-9C9A-6E6724E3D55B Q39006179-602FACEF-629F-4CCA-9A95-5179AE93B8F8 Q41010096-EE3EC3A7-74CA-4E47-B3FD-0091C5B6EE7D Q41689680-FA07C3B7-662B-46FC-9203-8AFCBD58721E Q41888025-26A89737-C2C7-4310-8FF2-C44537E08F25 Q42380027-73707225-4340-49B3-82E4-06C14E0F2E06 Q42552154-EDC8E170-1BDD-4FEA-9F51-3C6955D850A9 Q42970356-716194CE-CB73-4A31-B950-2864761CAA29 Q45181404-E338B0B3-322D-4D2D-B1D6-C6370FFD12A9

P2860

Persistence of prolonged C-peptide production in type 1 diabetes as measured with an ultrasensitive C-peptide assay

http://www.wikidata.org/entity/Q24600478

description

2012 nî lūn-bûn

@nan

2012 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մարտին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Persistence of prolonged C-pep ...... ultrasensitive C-peptide assay

@ast

Persistence of prolonged C-pep ...... ultrasensitive C-peptide assay

@en

Persistence of prolonged C-pep ...... ultrasensitive C-peptide assay

@nl

type

label

Persistence of prolonged C-pep ...... ultrasensitive C-peptide assay

@ast

Persistence of prolonged C-pep ...... ultrasensitive C-peptide assay

@en

Persistence of prolonged C-pep ...... ultrasensitive C-peptide assay

@nl

prefLabel

Persistence of prolonged C-pep ...... ultrasensitive C-peptide assay

@ast

Persistence of prolonged C-pep ...... ultrasensitive C-peptide assay

@en

Persistence of prolonged C-pep ...... ultrasensitive C-peptide assay

@nl

P1433

Q24600478-A619EA46-4CC1-4B43-AB6B-2F3A8BDB4D71

P1476

Q24600478-635F8DFF-8A87-4736-B3DD-352110BC3013

P2093

Q24600478-4FAEC922-EC29-448B-AA11-B421BDFC48AB

Q24600478-52659F76-74D9-4170-911A-8CC89228A2C2

Q24600478-EBC92013-46FC-4386-B1BC-D621856AECAF

P2860

Q24600478-0E8FFDDF-5775-4C6A-AE07-12FC71CBDAD7

Q24600478-0F89667D-B754-4B3C-85CE-67582DF1D69A

Q24600478-1B2F263D-5141-467F-8BEE-157AF890B30B

Q24600478-34EEA376-A6A0-4422-AA42-514F3A06B926

Q24600478-3589D3DC-D3A5-45D9-9AAE-8BAD08C13530

Q24600478-528561ED-A2F9-4CC8-881A-E51E320B3503

Q24600478-5A492B87-469B-4BD6-968F-AB48D3F77813

Q24600478-5D538E0D-0463-456A-BCC1-2448D606D2B2

Q24600478-660A2C50-4CB8-4A9B-B5BA-B69095910CB6

Q24600478-7504A200-1C1B-466C-BD58-0996E57BF9BB

P304

Q24600478-70EC846D-15C2-4420-A48E-85C10DD29318

P31

Q24600478-46EDB1C9-D0DD-4B4F-9EB9-1B61EB1A4F1D

P3181

Q24600478-81C70A2B-AEE5-4377-B08C-E5588F32DAA7

P356

Q24600478-02A5EA17-E1A9-405D-A4C2-B1C11D1452B3

P407

Q24600478-D0F8C869-13D0-4900-AFD8-5E7518E76333

P433

Q24600478-DF0907F1-7B39-463B-A846-4B888AAF4536

P478

Q24600478-50CE4A16-A069-4A7D-94AD-E27E0121885D

P577

Q24600478-01CE6F60-8DA8-4869-8765-253EE61C76D3

P5875

Q24600478-8671E47F-1816-47DA-A650-1B130873FD8F

P698

Q24600478-F4B860D5-C37B-4714-A719-BA14C7CE3E42

P921

Q24600478-4DD94BC2-6805-46FA-BA33-234EF913F993

P932

Q24600478-E6525E65-5125-4B6A-BEDF-9005F2CEA1C1

P3181

P356

P1433

P1476

Persistence of prolonged C-pep ...... ultrasensitive C-peptide assay

@en

P2093

Denise L Faustman

http://www.w3.org/2001/XMLSchema#string

Limei Wang

http://www.w3.org/2001/XMLSchema#string

Nicholas Fraser Lovejoy

http://www.w3.org/2001/XMLSchema#string

P2860

Residual insulin production and pancreatic ß-cell turnover after 50 years of diabetes: Joslin Medalist Study.

Kinetics of the post-onset decline in zinc transporter 8 autoantibodies in type 1 diabetic human subjects.

Natural history of beta-cell function in type 1 diabetes.

Beta-cell mass and type 1 diabetes: going, going, gone?

Fasting plasma C-peptide and micro- and macrovascular complications in a large clinic-based cohort of type 1 diabetic patients

Pancreatic beta cell function persists in many patients with chronic type 1 diabetes, but is not dramatically improved by prolonged immunosuppression and euglycaemia from a beta cell allograft.

Prevalence of residual beta-cell function in insulin-dependent diabetics in relation to age at onset and duration of diabetes.

Persistent insulin secretion, assessed by plasma C-peptide estimation in long-term juvenile diabetics with a low insulin requirement.

Reduced beta-cell secretion and insulin hepatic extraction in healthy elderly subjects.

Factors affecting and patterns of residual insulin secretion during the first year of type 1 (insulin-dependent) diabetes mellitus in children.

P304

465-70

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2233605

http://www.w3.org/2001/XMLSchema#string

P356

10.2337/DC11-1236

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P577

2012-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221851828

http://www.w3.org/2001/XMLSchema#string

P698

22355018

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

P932

3322715

http://www.w3.org/2001/XMLSchema#string